Health ❯ Healthcare

Medical Research

Cancer Research Clinical Trials Oncology Cancer Treatment Clinical Studies Neurology Cardiology Pharmacology Genetics Gene Therapy

RMIT Engineers Nanodots That Kill Cancer Cells in Lab Tests While Largely Sparing Healthy Cells

Chemically tuned molybdenum-oxide particles raise oxidative stress without light activation.

Trump Orders Faster Federal Move To Reclassify Marijuana To Schedule III

Longitudinal Study Finds One in Four U.S. Adults Faces Unaffordable Care or Skips Treatment

AstraZeneca’s LATIFY Phase 3 Finds No Survival Benefit for Ceralasertib Plus Imfinzi in Pre-Treated NSCLC

Trump Orders Marijuana Shift to Schedule III, Kicking Off Federal Rulemaking

Trump Signs Order to Push Marijuana Rescheduling to Schedule III

Largest Blood-Test Study Finds Alzheimer’s Changes Common in Older Adults

FDA Adds Brain Tumor Warning to Two Depo‑Provera Injections

Nature Papers Reveal 'Reverse' GPCR Switch That Boosts Opioid Analgesia in Preclinical Tests

Tilray Surges as Trump Weighs Marijuana Reclassification to Schedule III

Dana-Farber to Pay $15 Million to Resolve DOJ Claims Over Manipulated Data in NIH-Funded Studies

University of Michigan AI Detects Microvascular Heart Disease From a 10-Second EKG

T Cell Receptor Switches From Closed to Open in Native Membrane, Rewriting Activation Model

Study Finds CBD–THC Combination Kills Ovarian Cancer Cells in Lab

Sanofi Ends PPMS Bid After Tolebrutinib Fails Phase 3 as FDA Delays Review for nrSPMS

Lilly’s Imlunestrant Data Show Stronger Results With Abemaciclib, Delayed Chemotherapy in ER+ Breast Cancer

Study Finds No Added Breast Cancer Risk From Menopausal Hormone Therapy in BRCA Carriers

Lancet Phase III Trial Finds Proton Therapy Improves 5-Year Survival in Oropharyngeal Cancer

Final Phase I Data Show Preventive TNBC Vaccine Is Safe and Induces Immune Responses in Most Participants

15-Minute HCV RNA Test Validated With 100% Agreement in Johns Hopkins Study